Metabolic secondary findings Two secondary metabolic signals stood out: 72% of participants with prediabetes at baseline reverted to normoglycemia by the end of treatment
Reports of GLP-1-associated gastroparesis have increased as prescribing has expanded
Immunity and Resilience Reviewed when patients want to discuss immune health, resilience, inflammation support, recovery patterns, and broader wellness planning
After treatment initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)
Semaglutide offers a compelling combination of efficacy, weight loss benefits, cardiovascular protection, and flexible administration options, setting it apart from other diabetes medications
I feel in control again and I'm down 61 pounds since getting started